Focus10TH ANNIVERSARY SERIES

Wrangling RNA: Antisense oligonucleotides for neurological disorders

See allHide authors and affiliations

Science Translational Medicine  25 Sep 2019:
Vol. 11, Issue 511, eaay2069
DOI: 10.1126/scitranslmed.aay2069

Article Information

vol. 11 no. 511

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication July 22, 2019
  • Accepted for publication September 9, 2019
  • .

Author Information

  1. Kevin Talbot1,2,* and
  2. Matthew J. A. Wood2,3,4
  1. 1Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
  2. 2MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford OX1 3QX, UK.
  3. 3Department of Paediatrics, University of Oxford, Oxford OX1 3QX, UK.
  4. 4Oxford Harrington Rare Disease Centre, University of Oxford, Oxford OX1 3QX, UK.
  1. *Corresponding author. Email: kevin.talbot{at}ndcn.ox.ac.uk(K.T.); matthew.wood{at}paediatrics.ox.ac.uk (M.J.A.W.)

Altmetric

Article usage

Article usage: September 2019 to August 2020

AbstractFullPdf
Sep 20192392319499
Oct 2019197796277
Nov 2019223232117
Dec 2019755237106
Jan 2020693273105
Feb 202064925273
Mar 202026516053
Apr 20201911260
May 20201110785
Jun 2020157655
Jul 202084270
Aug 2020122

Stay Connected to Science Translational Medicine

Navigate This Article